Will STZ Stock Benefit from Its Fiscal 1Q18 Results?
Constellation Brands (STZ) stock has risen 20.4% to $184.57 as of June 23, 2017. The company has outperformed other major nonalcoholic beverage companies’ stocks on a year-to-date (or YTD) basis.
On June 23, the stock prices of Anheuser-Busch InBev (BUD), Molson Coors Brewing Company (TAP), and Brown-Forman (BF.B) had risen 7.5%, -11.1%, and 8.9%, respectively, YTD. Constellation Brands has outperformed the S&P 500 Index, which has risen 8.9% since the start of the year.
Interested in BUD? Don't miss the next report.
Receive e-mail alerts for new research on BUD
On June 23, 13 out of 19 analysts (or 68%) had “buy” recommendations on Constellation Brands stock. Six analysts had “hold” recommendations, and none had “sell” recommendations on the stock.
Constellation Brands has delivered strong results in recent quarters on the strength of its Mexican beer brands, including Corona Extra and Modelo Especial. The company’s premiumization strategy is further boosting its sales and profitability. As part of its strategy to focus on premium brands, the company has made several strategic acquisitions such as those of Ballast Point, Prisoner wine brands, and the Meiomi wine business.
12-month price target
On June 23, STZ’s 12-month price target was $191.83. This price target reflects an upside potential of ~4% compared to the company’s closing stock price on June 23. The company’s fiscal 1Q18 results, scheduled for release on June 29, will likely result in an upward or downward revision in its average price target.
Let’s look at STZ’s valuation in the next part of this series.